ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
118 hedge funds and large institutions have $1.55B invested in iTeos Therapeutics in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
53% more funds holding
Funds holding: 77 → 118 (+41)
6.23% more ownership
Funds ownership: 88.47% → 94.71% (+6.2%)
Holders
118
Holding in Top 10
7
Calls
–
Puts
–
Top Buyers
| 1 | +$21M | |
| 2 | +$20.6M | |
| 3 | +$20.5M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$10.8M |
| 5 |
Millennium Management
New York
|
+$10.6M |
Top Sellers
| 1 | -$21M | |
| 2 | -$18.9M | |
| 3 | -$12.2M | |
| 4 |
Citigroup
New York
|
-$9.54M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$9.02M |